z-logo
open-access-imgOpen Access
Survival analysis of time to develop cardiovascular complications and its predictors among hypertensive patients treated in the Ayder Comprehensive Specialized Hospital, Ethiopia: a retrospective cohort study (RCD code: VIII)
Author(s) -
Degena Bahrey Tadesse,
Gebreye Yitayih,
Weyzer Tilahun,
Gebreamlak Gebremedhn,
Kiros Belay,
Berihu Hailu,
Yohannes Godie Ashebir,
Gebre Teklemariam Demoz,
Mulugeta Molla
Publication year - 2020
Publication title -
journal of rare cardiovascular diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.1
H-Index - 2
eISSN - 2300-5505
pISSN - 2299-3711
DOI - 10.20418/jrcd.vol4no3.386
Subject(s) - medicine , blood pressure , proteinuria , retrospective cohort study , incidence (geometry) , cohort , complication , cohort study , pediatrics , kidney , physics , optics
Objective: Although hypertension is the leading cause of cardiovascular complications, time to develop cardiovascular complications among hypertensive patients has not been adequately investigated in Ethiopia. Therefore, the aim of this study was to assess time to develop cardiovascular complications and its predictors among adult hypertensive patients at the Ayder Comprehensive Specialized Hospital, Ethiopia. Result: A total of 578 hypertensive patients from the Cardiology Department were included in the study and followed for a total of 60 months (median 28 months). Half of the participants (290, 50.2%) were females. The median age of subjects was 54 years. Out of the 578 hypertensive patients who were analysed, 25.4% of them developed a cardiovascular complication. The incidence rate was 8.25 per 1000 persons per month. Significant predictors in the development of cardiovascular complications among hypertensive patients were age [AHR = 1.03 (95% CI=1.016, 1.046)], baseline cardiovascular complications [AHR=3.03 (95% CI=2.009, 4.870)], proteinuria [AHR=3.9 (95% CI=1.3, 11.68)], baseline systolic blood pressure [AHR =1.01 (95% CI=1.003, 2.012)], and baseline diastolic blood pres‐sure [AHR = 1.013 (95% CI=1.005, 2.021)]. JRCD 2019; 4 (4): 96-100.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom